Docaravimab
Based on 1 Customer Validation
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
For research use only. We do not sell to patients.
- Purity : 99.27%
- CAS No.: 2247196-23-0
- Molecular Weight:146.48 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
ERA
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized human Rabies virus Glycoprotein G His Tag can bind Docaravimab. The EC50 for this effect is 12.13 ng/mL.
Product Details
-
CAS No. 2247196-23-0
-
Synonyms 62-71-3
-
Molecular Weight 146.48 kDa
-
Species Reactivity
Rabies lyssavirus
-
Conjugated
Unconjugated
-
Isotype
Mouse IgG2b kappa
-
Recommend Isotype Controls
-
Format
-
IgG2b-kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
99.27%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)